- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
15
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
15 companies
Viatris
Market Cap: US$18.7b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$16.28
7D
-8.0%
1Y
60.9%
Exelixis
Market Cap: US$13.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$51.33
7D
-8.3%
1Y
35.3%
Elanco Animal Health
Market Cap: US$11.1b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.73
7D
-11.2%
1Y
30.4%
Tango Therapeutics
Market Cap: US$4.0b
A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
TNGX
US$26.34
7D
-10.3%
1Y
289.6%
Bicara Therapeutics
Market Cap: US$1.8b
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$23.76
7D
-9.0%
1Y
126.9%
Maravai LifeSciences Holdings
Market Cap: US$1.6b
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$5.81
7D
-9.6%
1Y
116.0%
Tyra Biosciences
Market Cap: US$1.6b
A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.
TYRA
US$25.18
7D
-22.6%
1Y
137.5%
Eton Pharmaceuticals
Market Cap: US$1.2b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$42.05
7D
-8.2%
1Y
142.8%
Olema Pharmaceuticals
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.
OLMA
US$10.43
7D
-11.3%
1Y
96.4%
Agenus
Market Cap: US$315.1m
A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.
AGEN
US$6.83
7D
-17.7%
1Y
42.0%
Zentalis Pharmaceuticals
Market Cap: US$297.4m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.
ZNTL
US$4.11
7D
-15.8%
1Y
191.5%
Coherus Oncology
Market Cap: US$191.6m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.21
7D
-18.2%
1Y
32.1%
Kalaris Therapeutics
Market Cap: US$93.7m
A clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases.
KLRS
US$3.97
7D
-8.1%
1Y
59.4%
CapForce
Market Cap: US$49.5m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$5.52
7D
-18.8%
1Y
5,519,900.0%
Universe Pharmaceuticals
Market Cap: US$4.6m
Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
UPC
US$5.94
7D
-15.7%
1Y
74.2%